[vc_row][vc_column][vc_column_text css_animation=”top-to-bottom”]

Fortune 500 Pharmaceutical Company Restructure Analysis and Divestiture Strategy (client confidential)

[/vc_column_text][vc_separator border_width=”3″][/vc_column][/vc_row][vc_row][vc_column width=”1/3″ css=”.vc_custom_1457392646708{padding-right: 50px !important;}”][distance][vc_single_image image=”5782″ img_size=”full”][/vc_column][vc_column width=”2/3″][vc_column_text][list-ul type=”arrow”]

[li-row]Financial restructure and divestiture analysis of a biotechnology and R&D facility[/li-row]

[li-row]Asset and liability assessment, quantification, monetization, and mitigation analysis including environmental remediation and demolition liabilities[/li-row]

[li-row]Market feasibility study and highest and best use analysis and development of a campus master plan for mixed use retail, hospitality and office building use/reuse[/li-row]

[li-row]Identification and financial analysis of a range of divestiture/reuse options including self-development, sale “as is, where is”, mixed use residential/commercial, custodial care for future use

[/li-row][/list-ul]

[/vc_column_text][vc_column_text][ssbp][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

[/vc_column_text][/vc_column][/vc_row]